National Health Investors Receives a Buy from Stephens

By Ryan Adsit

Stephens analyst Dana Hambly reiterated a Buy rating on National Health Investors (NYSE: NHI) today and set a price target of $79. The company’s shares closed yesterday at $71.11.

According to, Hambly is a 2-star analyst with an average return of 2.5% and a 50.0% success rate. Hambly covers the Services sector, focusing on stocks such as Encompass Health Corporation, Capital Senior Living, and Team Health Holdings.

National Health Investors has an analyst consensus of Hold, with a price target consensus of $78.

Based on National Health Investors’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $71.35 million and quarterly net profit of $39.09 million. In comparison, last year the company earned revenue of $71.2 million and had a net profit of $41.19 million.

Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NHI in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes independent and assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.